News

‘Psychedelics and the Texas Trip’ explores science & history behind state-funded research initiative

Texas recently approved $50 million in public funding, matched privately, to study ibogaine—a plant-derived psychedelic—as a potential treatment for PTSD, TBI, addiction, and related conditions. The initiative is facilitated through a public–private partnership and includes protections to ensure future therapy revenues fund veterans’ programs

Texas passes nation’s first ibogaine research funding bill; Colorado’s first Natural Medicine client; and Psilocybin’s effects wane a year after dosing

Texas is the first state to fund clinical trials of ibogaine, investing $50 million in public funds to explore its potential for treating PTSD, addiction, and TBI—with future revenues supporting veterans’ programs.

Texas governor signs bill allocating up to $100 million in funding for psychedelics research

Texas has passed a landmark bill dedicating up to $100 million—half from public funds—to study ibogaine for conditions like PTSD, TBI, and addiction. A portion of future revenue will directly support veterans’ programs, marking a major step toward expanding access to psychedelic-assisted therapies.

Los Angeles Times: California Veterans Fight to Fast-Track Study of ‘Lifesaving’ Psychedelic Therapy

Veterans Exploring Treatment Solutions (VETS) Takes Center Stage at Psychedelic Science 2025

Veterans Exploring Treatment Solutions (VETS) brought its mission to the forefront at Psychedelic Science 2025, spotlighting the urgent need for access, equity, and innovation in veteran mental health. From policy advocacy to powerful storytelling, VETS delivered a bold message: healing is a right—and veterans deserve the freedom to pursue it.

How the Legacy of the “Bonus Army” Inspired a Modern Protest Movement of Military Veterans

Nearly a century after the original Bonus Army marched on Washington, veterans are once again mobilizing—this time to defend federal jobs, safeguard VA services, and demand dignity. On June 6, the “Bonus Army of 2025” returns to the Capitol, continuing a legacy of veteran-led advocacy. Among them are voices from VETS, helping elevate the call for respect, accountability, and access to the care veterans have earned.

NC lawmakers call for new look at psychedelic drugs for mental health therapy

Bipartisan momentum is building in North Carolina as lawmakers propose a new task force to explore the clinical use of psychedelic-assisted therapies for mental health. Backed by veterans, advocates, and legislators across the aisle, Senate Bill 568 signals a growing recognition of the urgent need for innovative solutions to the mental health crisis.

The Inner Work of Being a Dad

VETS’ Director of Men’s Programs, Eric “Moose” Smith, reflects on fatherhood as a living practice of healing. Through the lens of parenting and psychedelic-assisted therapy, Moose explores how his greatest growth has come not from retreats—but from learning to stay present, soften, and love well at home.

Psychedelic State(s) of America Puts A Spotlight On Texas

In the debut of Lucid News' “Psychedelic State(s) of America” series, Texas takes center stage as lawmakers and advocates unite behind HB 3717—pushing forward $50 million in state-backed ibogaine research. With powerful voices like VETS co-founders Amber and Marcus Capone influencing legislative momentum, the Lone Star State is emerging as a surprising leader in psychedelic policy reform for veterans and beyond.

From Momentum to Movement: Q1 Advocacy Wins & What Comes Next

VETS Legislative Director Logan Davidson recaps Q1 2025's landmark policy wins—from Texas to Georgia—and previews what’s next in the fight for safe, legal access to psychedelic-assisted therapies for veterans. This momentum is real—and the movement is growing.